Evidence map›Paper›PMID 26816508›Full record

ReviewJournal of contemporary brachytherapy2015

Brachytherapy in non melanoma skin cancer of eyelid: a systematic review.

Rezarta Frakulli, Andrea Galuppi, Silvia Cammelli, Gabriella Macchia, Simona Cima, Maria A Gambacorta, Ines Cafaro, Luca Tagliaferri, Elisabetta Perrucci, Milly Buwenge and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of contemporary brachytherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Expert opinion: radiotherapy for basal cell carcinoma : Recommendations from the DEGRO Dermatooncology Working Group.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
  3. Considerations on HDR brachytherapy for eyelid carcinoma.Journal of contemporary brachytherapy · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Rezarta FrakulliRadiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Andrea GaluppiRadiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Silvia CammelliRadiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Gabriella MacchiaRadiation Oncology Unit, Research and Care Foundation 'Giovanni Paolo II', Catholic University of Sacred Heart, Campobasso, Italy.
Simona CimaRadiation Oncology Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Maria A GambacortaDepartment of Radiation Oncology, Catholic University of the Sacred Heart, Rome, Italy.
Ines CafaroDepartment of Radiation Oncology, Istituti Ospitalieri, Cremona, Italy.
Luca TagliaferriDepartment of Radiation Oncology, Catholic University of the Sacred Heart, Rome, Italy.
Elisabetta PerrucciRadiation Oncology Section, Santa Maria della Misericordia Hospital, Perugia, Italy.
Milly BuwengeRadiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Giovanni FrezzaRadiation Oncology Unit, Bellaria Hospital, Bologna, Italy.
Vincenzo ValentiniDepartment of Radiation Oncology, Catholic University of the Sacred Heart, Rome, Italy.
Alessio G MorgantiRadiation Oncology Center, Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.
Università Cattolica del Sacro Cuore · ITUniversity of Bologna · ITPoliclinico S.Orsola-Malpighi · ITInstitute of Oncology Research · CHIstituti Ospitalieri di Cremona · ITOspedale Bellaria · ITOspedale Santa Maria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNon melanoma skin cancers (NMSC) of eyelid are uncommon. Many treatments approach are available with surgery being considered as the gold standard. Radiotherapy is an effective alternative in patients unfit for surgery. Brachytherapy (BT) might be a better therapeutic option due high radiation dose concentration to the tumor and rapid dose fall-off resulting in normal tissues sparing. The aim of this review is to evaluate local control, toxicity, and functional cosmetic outcome of BT in NMSC of eyelid. MATERIAL AND

methodsA systematic search of the bibliographic databases PubMed, Scopus, and Cochrane Library from the earliest possible date through October 2015 was performed. Only studies published in English were included.

resultsSix articles fulfilled the selection criteria and were included in our review. Due to high risk of bias, all studies were classified to provide a low level of evidence (according to Scottish Intercollegiate Guidelines Network Classification). No randomized controlled trials or case control studies were founded. Brachytherapy was well tolerated with acceptable toxicity and high local control rates (median: 95.2%). Functional and cosmetic outcome were reported in five study as acceptable good functional-cosmetic outcome (median: 100%).

conclusionsTo date, few evidences are available on the role of BT in eyelid NMSC, and they show satisfactory results in terms of local control and functional cosmetic outcome. Therefore, prospective controlled trials are justified.

Indexed as

brachytherapyeyelidnon melanoma skin cancersystematic review

Identifiers

PMID26816508
PMCPMC4716127
OpenAlexW2317869702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.